Adjuvant therapy for high-risk renal cell carcinoma patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-007-0017-5.pdf
Reference74 articles.
1. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10–30.
2. Cohen HT, McGovern FJ: Renal-cell carcinoma. N Engl J Med 2005, 353:2477–2490.
3. Jayson M, Sanders H: Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998, 51:203–205.
4. Lam JS, Shvarts O, Leppert JT, et al.: Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005, 173:1853–1862.
5. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Path 1982, 6:655–663.
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis;European Urology;2021-11
2. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review;Translational Andrology and Urology;2020-12
3. Neoadjuvant Targeted Molecular Therapy Before Renal Surgery;Urologic Clinics of North America;2017-05
4. Adjuvant Therapy for Renal Cell Carcinoma;Clinical Genitourinary Cancer;2014-12
5. Small Renal Masses: Surgery or Surveillance;Korean Journal of Urology;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3